This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 1974 Oct;53(5):223-8.

Effects of a GABA--derivative (BA-34647) on spasticity. Preliminary report of a double-blind cross-over study

J V Basmajian, V Yucel

PMID: 4153338

Clinical Trial

Effects of a GABA--derivative (BA-34647) on spasticity. Preliminary report of a double-blind cross-over study

J V Basmajian et al. Am J Phys Med. 1974 Oct.

. 1974 Oct;53(5):223-8.

Authors

J V Basmajian, V Yucel

PMID: 4153338

No abstract available

PubMed Disclaimer

Similar articles

Liorseal, a new muscle relaxant in the treatment of spasticity--a double-blind quantitative evaluation.
Levine IM, Jossmann PB, DeAngelis V. Levine IM, et al. Dis Nerv Syst. 1977 Dec;38(12):1011-5. Dis Nerv Syst. 1977. PMID: 338269 Clinical Trial. No abstract available.
Management of flexor spasms with Lioresal.
Shahani BT, Young RR. Shahani BT, et al. Arch Phys Med Rehabil. 1974 Oct;55(10):465-7. Arch Phys Med Rehabil. 1974. PMID: 4153400 No abstract available.
An objective assessment of a gamma aminobutyric acid derivative in the control of spasticity.
Burke D, Gillies JD, Lance JW. Burke D, et al. Proc Aust Assoc Neurol. 1971;8:131-4. Proc Aust Assoc Neurol. 1971. PMID: 4949207 Clinical Trial. No abstract available.
[Intrathecal baclofen for severe spasticity].
Ueta T. Ueta T. Brain Nerve. 2008 Dec;60(12):1415-20. Brain Nerve. 2008. PMID: 19110752 Review. Japanese.
Functional effects of spinal baclofen.
Müller H. Müller H. Przegl Lek. 2007;64 Suppl 2:1-2. Przegl Lek. 2007. PMID: 17953269 Review. No abstract available.

See all similar articles

Cited by

Evidence basis for treatment of spasticity.
Dawson DM. Dawson DM. Curr Neurol Neurosci Rep. 2001 Nov;1(6):501-6. doi: 10.1007/s11910-001-0051-5. Curr Neurol Neurosci Rep. 2001. PMID: 11898562 Review. No abstract available.
A benefit-risk assessment of baclofen in severe spinal spasticity.
Dario A, Tomei G. Dario A, et al. Drug Saf. 2004;27(11):799-818. doi: 10.2165/00002018-200427110-00004. Drug Saf. 2004. PMID: 15350152 Review.
Pharmacological interventions for spasticity following spinal cord injury.
Taricco M, Adone R, Pagliacci C, Telaro E. Taricco M, et al. Cochrane Database Syst Rev. 2000;2000(2):CD001131. doi: 10.1002/14651858.CD001131. Cochrane Database Syst Rev. 2000. PMID: 10796750 Free PMC article.
Interventions for managing skeletal muscle spasticity following traumatic brain injury.
Synnot A, Chau M, Pitt V, O'Connor D, Gruen RL, Wasiak J, Clavisi O, Pattuwage L, Phillips K. Synnot A, et al. Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD008929. doi: 10.1002/14651858.CD008929.pub2. Cochrane Database Syst Rev. 2017. PMID: 29165784 Free PMC article.
Anti-spasticity agents for multiple sclerosis.
Shakespeare DT, Young CA, Boggild M. Shakespeare DT, et al. Cochrane Database Syst Rev. 2000;2003(4):CD001332. doi: 10.1002/14651858.CD001332. Cochrane Database Syst Rev. 2000. Update in: Cochrane Database Syst Rev. 2001;(4):CD001332. doi: 10.1002/14651858.CD001332. PMID: 11034714 Free PMC article. Updated.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.